financetom
Business
financetom
/
Business
/
JetBlue flight rolls off runway at Boston airport, no injuries reported
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
JetBlue flight rolls off runway at Boston airport, no injuries reported
Jun 12, 2025 10:11 AM

June 12 (Reuters) - A JetBlue Airways ( JBLU ) flight

rolled off the runway at Boston Logan airport onto the grass

Thursday, prompting a ground stop, but no injuries were

reported.

JetBlue Flight 312, an Airbus A220, had arrived from Chicago

O'Hare and went into the grass while turning off the runway

around 11:55 a.m., the Federal Aviation Administration said,

adding it will investigate.

The airport authority is deplaning passengers via stairs and

transporting them by bus to the terminal.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Soccer-Sesko double but Man United held to 2-2 draw at lowly Burnley
Soccer-Sesko double but Man United held to 2-2 draw at lowly Burnley
Mar 10, 2026
BURNLEY, England, Jan 7 (Reuters) - Manchester United's ( MANU ) Benjamin Sesko scored twice as his team kicked off the post-Ruben Amorim era with a familiar sense of frustration in a ‌2-2 Premier League draw at lowly Burnley on Wednesday. United, with interim ​manager Darren Fletcher in charge, would have climbed ‍to fourth in the table with ⁠a win...
AbbVie in talks to buy biotech Revolution Medicines, WSJ reports
AbbVie in talks to buy biotech Revolution Medicines, WSJ reports
Mar 10, 2026
Jan 7 (Reuters) - AbbVie ( ABBV ) is in advanced talks to buy cancer-drug developer Revolution Medicines ( RVMD ), the Wall Street Journal reported on ‌Wednesday, citing people familiar with the matter. Shares ​of Revolution were up nearly ‍30% after the report. AbbVie's ( ABBV ) ⁠stock ⁠was up more than 5%. The potential deal could ‌be the...
Lilly moves beyond blockbuster obesity drugs with $1.2 billion Ventyx buy
Lilly moves beyond blockbuster obesity drugs with $1.2 billion Ventyx buy
Mar 10, 2026
By Puyaan Singh Jan 7 (Reuters) - Eli Lilly ( LLY ) will buy autoimmune drug developer Ventyx Biosciences ( VTYX ) for $1.2 billion in cash, the companies said on Wednesday, marking the Zepbound maker's latest push to expand beyond its ‌blockbuster diabetes and weight-loss drugs. Ventyx is developing several treatments, including oral therapies ​for inflammatory bowel diseases such...
Market Chatter: AbbVie in Advanced Talks to Acquire Revolution Medicines
Market Chatter: AbbVie in Advanced Talks to Acquire Revolution Medicines
Mar 10, 2026
03:01 PM EST, 01/07/2026 (MT Newswires) -- AbbVie ( ABBV ) is nearing a deal to acquire cancer-drug biotech company Revolution Medicines ( RVMD ) , The Wall Street Journal reported Wednesday, citing people familiar with the matter. Financial terms of a potential deal couldn't be learned, but Revolution could be valued at around $20 billion at a minimum, according...
Copyright 2023-2026 - www.financetom.com All Rights Reserved